卡培他滨可改善转移性结直肠癌的无进展生存期,但不能改善总生存期

D. Ilson
{"title":"卡培他滨可改善转移性结直肠癌的无进展生存期,但不能改善总生存期","authors":"D. Ilson","doi":"10.1056/NEJM-JW.NA54177","DOIUrl":null,"url":null,"abstract":"Recent randomized trials have indicated that maintenance therapy after initial chemotherapy for metastatic colorectal cancer (mCRC) may improve","PeriodicalId":19048,"journal":{"name":"NEJM Journal Watch","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2021-10-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Maintenance Capecitabine Improved Progression-Free but Not Overall Survival in Metastatic Colorectal Cancer\",\"authors\":\"D. Ilson\",\"doi\":\"10.1056/NEJM-JW.NA54177\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Recent randomized trials have indicated that maintenance therapy after initial chemotherapy for metastatic colorectal cancer (mCRC) may improve\",\"PeriodicalId\":19048,\"journal\":{\"name\":\"NEJM Journal Watch\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-10-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"NEJM Journal Watch\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1056/NEJM-JW.NA54177\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"NEJM Journal Watch","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1056/NEJM-JW.NA54177","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

摘要

最近的随机试验表明,转移性结直肠癌(mCRC)初始化疗后的维持治疗可能会改善
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Maintenance Capecitabine Improved Progression-Free but Not Overall Survival in Metastatic Colorectal Cancer
Recent randomized trials have indicated that maintenance therapy after initial chemotherapy for metastatic colorectal cancer (mCRC) may improve
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信